Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsHighmark Pennsylvania Addyi Prior Auth Coverage | …
    Ask Trek AI about this page
    CurrentHighmark PennsylvaniaPolicy N/A

    Medication Prior Authorization Form — Addyi (flibanserin)

    Customize your policy alerts

    Sign up for all Highmark Pennsylvania policy alerts

    Know when Highmark Pennsylvania releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This document is a medication prior authorization form used by Highmark Pennsylvania for requesting coverage of Addyi (flibanserin) and applies to prescribers submitting PA requests for members. It governs the information and clinical responses required to process initial and reauthorization requests.

    Policy Summary
    PayerHighmark Pennsylvania
    PolicyMedication Prior Authorization Form — Addyi (flibanserin)
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateN/A
    Next Review DateN/A
    Key ActionComplete and submit the Medication Information and Clinical Information sections, including diagnosis, alcohol/substance use status, medication history, and prescriber signature, via fax or mail.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    1medication form for a single drug (Addyi)
    2authorization types

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    1
    fax submissions
    1mailing address

    Coverage Criteria

    Initial Therapy — Covered when ALL of the following are met and documented on the form

    Covered when ALL of the following are met and documented on the form

    Initial Authorization Criteria: 1) Member has a diagnosis of HSDD (hypoactive sexual desire disorder) documented on the form; 2) Member does not have a current issue with alcohol or substance abuse (or status documented); 3) Member has been educated on Addyi administration including the potential adverse effects of alcohol consumption with Addyi; 4) If HSDD, documentation whether the diagnosis is related to a co-existing medical or psychiatric condition, substance abuse, or relationship issue (yes/no); 5) Behavioral therapy candidacy documented and whether member is enrolled or has experienced therapeutic failure of behavioral therapy for HSDD as applicable; 6) Medication history provided listing other medications tried and failed; 7) Prescriber certifies/completes and signs the form (provider attestation).

    All items correspond to checkboxes/questions and the medication history section on the form.

    Continuation Therapy / Reauthorization — Reauthorization requires documentation that BOTH conditions are met

    Reauthorization requires documentation that BOTH conditions are met

    Reauthorization Criteria: 1) Member is tolerating therapy with Addyi (yes); AND 2) Member is experiencing improved sexual desire from baseline while on therapy with Addyi (yes).

    Both yes responses are requested on the reauthorization section of the form.

    The form explicitly screens for current alcohol or substance abuse as part of the clinical information. A positive response to "Does the member have a current issue with alcohol or substance abuse?" indicates a contraindication or important caution for Addyi (flibanserin) and must be documented on the form. The form also requires documentation that the member has been educated about the risks of alcohol use with Addyi—providers must confirm whether the member "has been educated on Addyi administration including the potential adverse effects of alcohol consumption with Addyi."

    When HSDD is documented, the form requests further clinical context that can affect appropriateness of therapy: whether the HSDD is related to co-existing medical or psychiatric conditions, substance abuse, or relationship issues. Behavioral therapy considerations are captured as well—providers must indicate if the member is a candidate for behavioral therapy, currently enrolled, or has experienced therapeutic failure of behavioral therapy. These items must be completed and signed by the prescriber to support an initial authorization.

    Initial Therapy Requirements

    Initial Therapy — Initial authorization requires clinical and medication history details

    Initial authorization requires clinical and medication history details

    Initial Authorization for Addyi: Document HSDD diagnosis and relevant ICD-10 code; confirm current alcohol/substance abuse status (no current issue documented); confirm patient education about alcohol risks with Addyi; document whether HSDD is related to co-existing medical/psychiatric condition, substance abuse, or relationship issue; indicate behavioral therapy candidacy, enrollment status, or therapeutic failure as applicable; provide medication history listing other medications tried and failed; prescriber certifies/completes and signs the form.

    These items are captured by the Clinical Information and Medication History sections on the form.

    Continuation / Reauthorization Criteria

    Reauthorization — Reauthorization questions to assess continued benefit and tolerability

    Reauthorization questions to assess continued benefit and tolerability

    Reauthorization Assessment: Member tolerating therapy with Addyi AND member experiencing improved sexual desire from baseline while on therapy; medication history or other supporting documentation may be provided as needed.

    Both reauthorization questions are required on the form; provider may include updated medication history in the Medication History section.

    Provider Actions & Submission Requirements

    Prior Authorization

    Prior Authorization Required

    Prior authorization is required before services will be considered for coverage. Complete the Medication Information and Clinical Information sections in full, including the diagnosis and applicable ICD-10 code(s), drug name, strength, requested quantity, day supply, directions, and whether this is a new request or reauthorization. Fax or mail the completed form and all supporting clinical documentation as instructed. Authorization does not guarantee payment; payment is subject to member eligibility.

    • Complete Medication Information and Clinical Information sections including diagnosis / ICD-10 code(s).
    • Include drug name, strength, requested quantity, requested day supply (e.g., 30 or 90 days), and directions.
    • Fax completed form and clinical documentation to 1-866-240-8123 or mail to 120 Fifth Avenue, SPECARE, Pittsburgh, PA 15222.
    Step Therapy

    Step / Prior Therapy Documentation

    Provide a medication history documenting prior treatments tried and failed. For conditions where behavioral therapy is relevant, indicate whether the member is a candidate for behavioral therapy, currently enrolled, and whether behavioral therapy has failed. For reauthorization requests, document tolerance and clinical benefit compared to baseline.

    Coding and Dispensing Details

    Diagnosis codes requested on formICD-10
    ICD-10Diagnosis and/or ICD-10 code(s) (specific code to be provided by prescriber)
    Requested Day Supply — Day supply options
    Allowed day supply options30 days or 90 days (prescriber selects one on the form)
    Field location on formRequested Day Supply appears under Medication Information with checkboxes for 30 and 90 days
    Prescriber responsibilityPrescriber must specify requested day supply when completing the form

    Step Therapy / Prior Medication History

    RequirementProvider must document
    {"text":"Prior medication therapy","status":""},{"text":"List other medications the member has tried and failed (medication history section).","status":""}
    {"text":"Behavioral therapy status (if applicable)","status":""},{"text":"Indicate whether the member is a candidate for behavioral therapy, currently enrolled, and whether behavioral therapy has failed (questions 3b–3d on the form).","status":""}
    {"text":"Alcohol/substance use screening","status":""},{"text":"Document whether the member has a current issue with alcohol or substance abuse (clinical question 1).","status":""}
    {"text":"Education on alcohol risks","status":""},{"text":"Confirm the member has been educated on Addyi administration and the potential adverse effects of alcohol consumption with Addyi (clinical question 2).","status":""}

    Quantity Limits

    Addyi — Requested quantity and day supply
    Prescriber must specify quantityRequested Quantity to be provided by prescriber on the Medication Information section
    Prescriber must specify day supplyRequested Day Supply must be selected (30 days or 90 days) on the form
    Form sectionQuantity and day supply fields are located under Medication Information (Drug Name, Drug Strength, Requested Quantity, Requested Day Supply)

    Site of Care and Submission Methods

    Note

    Form Completion and Submission (Office)

    The prescribing physician (PCP or specialist) should complete and sign the form; submit the completed form and all clinical documentation via fax or mail using the contact information on the form.

    • Fax completed form and documentation to 1-866-240-8123
    • Mail to: 120 Fifth Avenue, SPECARE, Pittsburgh, PA 15222

    Background

    This prior authorization form is specific to requests for Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD). The Clinical Information section collects confirmation of HSDD diagnosis and asks the prescriber to identify whether the diagnosis is related to comorbid medical/psychiatric conditions, substance abuse, or relationship issues.

    The form requires documentation that the member has been educated about Addyi administration and the potential adverse effects of alcohol consumption when taking Addyi. It also captures behavioral therapy status (candidate, currently enrolled, or failed) to inform clinical appropriateness and prior-therapy considerations.

    Definitions

    hypoactive sexual desire disorder — definition / brief identifier
    TermHypoactive sexual desire disorder (HSDD)
    Form confirmationThe form asks: 'Does the member have a diagnosis of HSDD (hypoactive sexual desire disorder)?' with Yes/No response
    Related assessment itemsIf HSDD is present the form asks about relation to medical/psychiatric conditions, candidacy/enrollment/failure of behavioral therapy
    Policy Summary
    PayerHighmark Pennsylvania
    PolicyMedication Prior Authorization Form — Addyi (flibanserin)
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateN/A
    Next Review DateN/A
    Key ActionComplete and submit the Medication Information and Clinical Information sections, including diagnosis, alcohol/substance use status, medication history, and prescriber signature, via fax or mail.
    SourceLink
    On This Page
    Coverage CriteriaInitial Therapy RequirementsContinuation / Reauthorization CriteriaProvider Actions & Submission RequirementsCoding and Dispensing DetailsStep Therapy / Prior Medication HistoryQuantity LimitsSite of Care and Submission MethodsBackgroundDefinitions
    • List other medications the member has tried and failed (include dates, doses, and reason for discontinuation where available).
    • If applicable, answer behavioral therapy questions: candidate for behavioral therapy; currently enrolled; therapeutic failure of behavioral therapy.
    • For reauthorization: document tolerance of therapy and improvement in symptoms from baseline.
    Documentation Required

    Required Submission Documentation

    Include complete member and provider identifying information, medication details, clinical answers to form questions, and the prescribing physician's signature and date. Ensure physician address and contact information are provided. Submit all supporting clinical documentation (chart notes, test results, specialty consults) with the form.

    • Member information: subscriber ID, group number, member name, DOB, phone, address.
    • Provider information: physician name, NPI, phone, fax, address, suite/building, physician signature and date.
    • Medication details: drug name, strength, quantity, day supply, directions, diagnosis / ICD-10 code(s).
    • Attach supporting documentation (clinical notes, test results, prior medication records).
    Denial Risk

    Incomplete Information May Cause Denial

    Incomplete, inaccurate, or missing information may delay review or result in denial. The submitting provider certifies the information is true, accurate, and complete. Remember: authorization approval does not guarantee payment; payment depends on member eligibility and plan benefits.

    • Incomplete forms or missing clinical documentation may prevent payment or lead to denial.
    • Provider certification statement must be included; signature and date required.
    • Authorization is not a guarantee of payment — verify member eligibility and benefits.